Role of Helicobacter pylori infection in the pathogenesis of minimal hepatic encephalopathy and effect of its eradication

Indian Journal of Gastroenterology

Volumn 30, Issue 1, 2011, Pages 29-32

  Agrawal, Avinash ^a   Gupta, Alok ^a   Chandra, Mam ^a   Koowar, Sciddhartha ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Ammonia; Liver cirrhosis; Minimal hepatic encephalopathy

Indexed keywords

AMMONIA; ANTIINFECTIVE AGENT; UREASE;

ADULT; AMMONIA BLOOD LEVEL; ARTICLE; ENDOSCOPY; ENZYME ASSAY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERAMMONEMIA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PSYCHOMETRY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AMMONIA; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MALE; PSYCHOMETRICS; TINIDAZOLE;

EID: 79954617692     PISSN: 02548860     EISSN: 02548860     Source Type: Journal    
DOI: 10.1007/s12664-011-0087-7     Document Type: Article

References (17)

1. Mullen KD, Dasarthy S. Hepatic Encephalopathy. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's Disease of the Liver. 8th ed. Philadelphia: Lippincott-Raven; 1990. p. 545-81.
2. Butterworth RF. Complications of cirrhosis III: Hepatic Encephalopathy. J Hepatol. 2000; 32 Suppl 1: 171-86.
3. Quero JC, Schalm SW. Subclinical hepatic encephalopathy. Semin Liver Dis. 1996; 16: 321-8.
4. Dhiman RK, Saraswat VA, Verma M, et al. Figure connection test: A universal test for assessment of mental state. J Gastroenterol Hepatol. 1995; 10: 726-31.
5. Gubbins GP, Moritz TE, Marsano LS, et al. The Veterans Administration Cooperative Study Group No. 275. Helicobacter pylori is a risk factor for hepatic encephalopathy in acute alcoholic hepatitis: The ammonia hypothesis revised. Am J Gastroenterol. 1993; 88: 1907-9.
6. Miyaji H, Ito S, Azuma T, et al. Effect of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis. Gut. 1997; 40: 726-30.
7. Ito S, Miyaji H, Azuma T, et al. Hyperammonaemia and Helicobacter pylori. Lancet. 1995; 346: 124-5.
8. Quero JC, Hartmann IJC, De Rooij F, et al. Hyperammonamia and Helicobacter pylori. Lancet. 1995; 346: 713-4.
9. Plevris JN, Morgenstern R, Hayes PC, Bouchier IAD. Hyperammonaemia in cirrhosis and Helicobacter pylori infection. Lancet. 1995; 346: 1104.
10. Mousseau DD, Butterworth RF. Current theories on the pathogenesis of hepatic encephalopathy. Proc Soc Exp Biol Medi. 1994; 206: 329-44.
11. Rilandi V, Zullo A, Diana F, Capocaccia L. Helicobacter pylori, Hyperammonemia and hepatic encephalopathy: is there a correlation? Am J Gastroenterol. 1997; 92: 723-34.
12. Vásconez C, Elizalde JI, Llach J, et al. Helicobacter pylori hyperammonemia and subclinical portosystemic encephalopathy: Effects of eradication. J Hepatol. 1999; 30: 260-4.
13. Quero JC, Hartmenn IJ, De Rooij F, Wilson JH, Schalm SW. Hyperammonaemia and Helicobacter pylori. Lancet. 1995; 346: 713-4.
14. Calvet X, Navarro M, Gill M, et al. Seroprevalence and epidemiology of Helicobacter pylori infection in patients with cirrhosis. J Hepatol. 1997; 26: 1249-54.
15. Rossle M, Haag K, Ochs A. et al. Helicobacter pylori infection is not associated with an increased risk of hepatic encephalopathy (abstract). Hepatology. 1994; 20: 111A.
16. Huber M, Rössle M, Siegerstetter V, et al. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis Hepatogastroenterology. 2001; 48: 541-4.
17. Watanabe A, Sakai T, Sato S, et al. Clinical efficacy of Lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. Hepatology. 1997; 26: 1410-4.